Milissa Cerio Clinical Counsel - NY Chemung, Elmira 14901

Milissa Cerio Clinical Counsel entered the industry of Outpatient Services in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 621420, which describes it as a Outpatient Services. For further clarification, the SIC classifies this business under the code 8093 and described it as a Outpatient Services. The business provides service to the B2C market.

To acquire more information, please contact Milissa Cerio by calling (607) 734-0096 during business hours. You can also write to the business’ Single Location at 100 North Main St # 214, Elmira, New York NY 14901. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Milissa Cerio Clinical Counsel
Representative: Milissa Cerio
Place of Business: 100 North Main St # 214, Elmira, NY 14901
Contact Number: (607) 734-0096
Type of Service: Outpatient Services
SIC Number: 8093
NAICS Number: 621420
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2005
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Milissa Cerio Clinical Counsel is a company operating from Chemung, New York providing professional Outpatient Services and relevant B2C variables. It was founded in 2005 and registered with the SIC code 8093 as Outpatient Services, and with the NAICS code 621420 as Outpatient Services.

With a current employee count of 1 to 4, Milissa Cerio Clinical Counsel has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Milissa Cerio at (607) 734-0096 for related queries, or to locate its Single Location using the coordinates 42.087787,-76.806995.

The Single Location can also be found at the street address 100 North Main St # 214 in Elmira, New York 14901 and can be engaged online through the company website at , the company Twitter , and Facebook page .